A comparison of monoclonal antibodies against murine PD-1 and PD-L1

被引：0
|
作者：
Bu, Melissa Tian
Yuan, Long
Klee, Alyssa
Freeman, Gordon J.
机构：
来源：
JOURNAL OF IMMUNOLOGY | 2022年 / 208卷 / 01期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.4049/jimmunol.208.Supp.176.05
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
176.05
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [32] Measurement of soluble PD-1 and soluble PD-L1 as well as PD-L1 and PD-1 from perioperative patients with gastric carcinoma
    Wei, Hangzhi
    Wu, Fahong
    Mao, Yudong
    Zhang, Youcheng
    Leng, Guangxian
    Wang, Jia
    Zhang, Wei
    Wang, Tianwei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (04) : 331 - 345
  • [33] PD-1–PD-L1 axis: efficient checkpoint blockade against cancer
    Alessia Errico
    Nature Reviews Clinical Oncology, 2015, 12 : 63 - 63
  • [34] Anti-VEGF/VEGFR2 Monoclonal Antibodies and their Combinations with PD-1/PD-L1 Inhibitors in Clinic
    Gao, Feng
    Yang, Chun
    CURRENT CANCER DRUG TARGETS, 2020, 20 (01) : 3 - 18
  • [35] Crystal clear: visualizing the intervention mechanism of the PD-1/PD-L1 interaction by two cancer therapeutic monoclonal antibodies
    Tan, Shuguang
    Chen, Danqing
    Liu, Kefang
    He, Mengnan
    Song, Hao
    Shi, Yi
    Liu, Jun
    Zhang, Catherine W. -H.
    Qi, Jianxun
    Yan, Jinghua
    Gao, Shan
    Gao, George F.
    PROTEIN & CELL, 2016, 7 (12) : 866 - 877
  • [36] Crystal clear:visualizing the intervention mechanism of the PD-1/PD-L1 interaction by two cancer therapeutic monoclonal antibodies
    Shuguang Tan
    Danqing Chen
    Kefang Liu
    Mengnan He
    Hao Song
    Yi Shi
    Jun Liu
    Catherine WHZhang
    Jianxun Qi
    Jinghua Yan
    Shan Gao
    George FGao
    Protein & Cell, 2016, 7 (12) : 866 - 877
  • [37] Determination of PD-L1 positive CETCs as a biomarker for PD-1/PD-L1 treatment monitoring
    Pizon, M.
    Schott, D.
    Pachmann, U.
    Pachmann, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 89 - 89
  • [38] The PD-1/PD-L1 Pathway in Human Pathology
    Saresella, M.
    Rainone, V.
    Al-Daghri, N. M.
    Clerici, M.
    Trabattoni, D.
    CURRENT MOLECULAR MEDICINE, 2012, 12 (03) : 259 - 267
  • [39] PD-1/PD-L1 Axis in Lung Cancer
    Santini, Fernando C.
    Hellmann, Matthew D.
    CANCER JOURNAL, 2018, 24 (01): : 15 - 19
  • [40] PD-1/PD-L1 as a prognostic factor in leukemia
    Hadi Rezaeeyan
    Seyedeh Nafiseh Hassani
    Mojgan Barati
    Mohammad Shahjahani
    Najmaldin Saki
    Journal of Hematopathology, 2017, 10 : 17 - 24
12345